✦ LIBER ✦

Feasibilty study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function

✍ Scribed by Joan Carles; Cristina Suárez; Carlos Mesía; Miquel Nogué; Albert Font; Montserrat Doménech; Marta Suárez; Ignasi Tusquets; M. Gallén; Joan Albanell; Xavier Fabregat

Book ID: 107596099
Publisher: Springer Milan
Year: 2006
Tongue: Spanish
Weight: 310 KB
Volume: 8
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-006-0123-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of cisplatin, irinotecan,

Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours

✍ Chen, X; Oza, A M; Kusenda, Z; Yi, Q-L; Kochman, D; Moore, M J; Davis, A J; Siu, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

Phase II trial of dose-dense doxorubicin

Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function

✍ Matthew D. Galsky; Alexia Iasonos; Svetlana Mironov; Joseph Scattergood; Mary G. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views